Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00315_DB00614> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00315_DB00614 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00614 label "DDI between Zolmitriptan and Furazolidone - The MAO inhibitor, furazolidine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing furazolidine are contraindicated. [drugbank_resource:DB00315_DB00614]" assertion.
- drugbank_resource:DB00315_DB00614 identifier "drugbank_resource:DB00315_DB00614" assertion.
- drugbank_resource:DB00315_DB00614 title "DDI between Zolmitriptan and Furazolidone - The MAO inhibitor, furazolidine, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing furazolidine are contraindicated." assertion.